NR3C1 and chronic obstructive pulmonary disease: Recently, our group has demonstrated that anti-muscarinic drugs, such as aclidinium bromide, increase the anti-inflammatory effects of corticosteroids inhibiting GR phosphorylation at serine 226, increasing GRE activity and the anti-inflammatory gene expression in neutrophils from COPD patients [9].